Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Research Article

Anti-cancer Activity of New Phosphoramide-functionalized Graphene Oxides: An Experimental and Theoretical Evaluation

Author(s): Khodayar Gholivand*, Mohammad Faraghi, Mahsa Pooyan, Leila Sarmadi Babaee, Rahime Eshaghi Malekshah, Foroogh Pirastehfar and Mohammad Vahabirad

Volume 30, Issue 30, 2023

Published on: 25 November, 2022

Page: [3486 - 3503] Pages: 18

DOI: 10.2174/0929867330666221027152716

Price: $65

Open Access Journals Promotions 2
Abstract

Background: Graphene oxide (GO)-based systems are among the drug delivery systems and have drawn a lot of interest in the field of medicine.

Methods: In this work, two novel phosphoramides with the formulas of (NHCHCH2C(CH3)2NHC(CH3)2CH2P(S)(OEt)2 (L1) and (NHCHCH2C(CH3)2 NHC (CH3)2CH2P (O) (NHC6H5) (OC5H6) (L2) were synthesized and characterized by spectroscopic methods. Then, graphene oxide (GO) was functionalized by L1 and L2. FT-IR, XRD, FE- SEM/ MAP, and Zeta potential analyses were applied to confirm the synthesis of phosphoramide-functionalized graphene oxides (GO-L1 and GO-L2). Cytotoxicity of synthesized compounds was evaluated against breast cancer cell line (SK-BR-3) using MTT assay. Moreover, the flow cytometry assay was performed to evaluate the cell death mechanisms.

Results: The results showed that GO-L1 and GO-L2 had a more inhibitory effect against cancer cells than that of L1 and L2, and GO-L2 showed the highest cytotoxicity with an IC50 value of 38.13 μg/ml. Quantum calculations were employed to optimize structures. HOMO and LUMO energy values and physical adsorption of synthesized compounds were obtained by the DMol3 module in the Material Studio 2017. The docking studies were used to investigate the binding of L1, L2, GO-L1, and GO-L2 to DNA polymerase IIα.

Conclusion: Anticancer activity of phosphoramide compounds was increased after attachment on the GO surface, and the docking studies' results were in good accordance with the experimental cytotoxicity results.

Keywords: Phosphoramide, functionalized graphene oxide, cytotoxicity studies, Monte Carlo adsorption, docking studies.

« Previous
[1]
Ferlay, J.; Shin, H.R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 2010, 127(12), 2893-2917.
[http://dx.doi.org/10.1002/ijc.25516] [PMID: 21351269]
[2]
Kayl, A.E.; Meyers, C.A. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr. Opin. Obstet. Gynecol., 2006, 18(1), 24-28.
[http://dx.doi.org/10.1097/01.gco.0000192996.20040.24] [PMID: 16493256]
[3]
Oun, R.; Moussa, Y.E.; Wheate, N.J. The side effects of platinum-based chemotherapy drugs: A review for chemists. Dalton Trans., 2018, 47(19), 6645-6653.
[http://dx.doi.org/10.1039/C8DT00838H] [PMID: 29632935]
[4]
Anirudhan, T.S.; Chithra Sekhar, V.; Athira, V.S. Graphene oxide based functionalized chitosan polyelectrolyte nanocomposite for targeted and pH responsive drug delivery. Int. J. Biol. Macromol., 2020, 150, 468-479.
[http://dx.doi.org/10.1016/j.ijbiomac.2020.02.053] [PMID: 32044367]
[5]
Anirudhan, T.S.; Deepa, J.R. Nano-zinc oxide incorporated graphene oxide/nanocellulose composite for the adsorption and photo catalytic degradation of ciprofloxacin hydrochloride from aqueous solutions. J. Colloid Interface Sci., 2017, 490, 343-356.
[http://dx.doi.org/10.1016/j.jcis.2016.11.042] [PMID: 27914333]
[6]
Fiorica, C.; Mauro, N.; Pitarresi, G.; Scialabba, C.; Palumbo, F.S.; Giammona, G. Double-network-structured graphene oxide-containing nanogels as photothermal agents for the treatment of colorectal cancer. Biomacromolecules, 2017, 18(3), 1010-1018.
[http://dx.doi.org/10.1021/acs.biomac.6b01897] [PMID: 28192653]
[7]
Dreyer, D.R.; Park, S.; Bielawski, C.W.; Ruoff, R.S. The chemistry of graphene oxide. Chem. Soc. Rev., 2010, 39(1), 228-240.
[http://dx.doi.org/10.1039/B917103G] [PMID: 20023850]
[8]
Namvari, M.; Namazi, H. Synthesis of magnetic citric-acid-functionalized graphene oxide and its application in the removal of methylene blue from contaminated water. Polym. Int., 2014, 63(10), 1881-1888.
[http://dx.doi.org/10.1002/pi.4769]
[9]
Liu, J.; Cui, L.; Losic, D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater., 2013, 9(12), 9243-9257.
[http://dx.doi.org/10.1016/j.actbio.2013.08.016] [PMID: 23958782]
[10]
McCallion, C.; Burthem, J.; Rees-Unwin, K.; Golovanov, A.; Pluen, A. Graphene in therapeutics delivery: Problems, solutions and future opportunities. Eur. J. Pharm. Biopharm., 2016, 104, 235-250.
[http://dx.doi.org/10.1016/j.ejpb.2016.04.015] [PMID: 27113141]
[11]
Muthoosamy, K.; Bai, R.; Manickam, S. Graphene and graphene oxide as a docking station for modern drug delivery system. Curr. Drug Deliv., 2014, 11(6), 701-718.
[http://dx.doi.org/10.2174/1567201811666140605151600] [PMID: 24909150]
[12]
Zhu, C.; Guo, S.; Fang, Y.; Dong, S. Reducing sugar: New functional molecules for the green synthesis of graphene nanosheets. ACS Nano, 2010, 4(4), 2429-2437.
[http://dx.doi.org/10.1021/nn1002387] [PMID: 20359169]
[13]
Demkowicz, S.; Rachon, J.; Daśko, M.; Kozak, W. Selected organophosphorus compounds with biological activity. Applications in medicine. RSC Advances, 2016, 6(9), 7101-7112.
[http://dx.doi.org/10.1039/C5RA25446A]
[14]
Kanis, J.A.; McCloskey, E.V. The use of clodronate in disorders of calcium and skeletal metabolism. In: Calcium metabolism; Karger Publishers: Basel, Switzerland, 1990; pp. 89-136.
[http://dx.doi.org/10.1159/000418528]
[15]
Mallender, W.D.; Szegletes, T.; Rosenberry, T.L. Acetylthiocholine binds to asp74 at the peripheral site of human acetylcholinesterase as the first step in the catalytic pathway. Biochemistry, 2000, 39(26), 7753-7763.
[http://dx.doi.org/10.1021/bi000210o] [PMID: 10869180]
[16]
De Clercq, E. Antivirals: Past, present and future. Biochem. Pharmacol., 2013, 85(6), 727-744.
[http://dx.doi.org/10.1016/j.bcp.2012.12.011] [PMID: 23270991]
[17]
Clercq, E.D.; Sakuma, T.; Baba, M.; Pauwels, R.; Balzarini, J.; Rosenberg, I.; Holý, A. Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines. Antiviral Res., 1987, 8(5-6), 261-272.
[http://dx.doi.org/10.1016/S0166-3542(87)80004-9] [PMID: 3451698]
[18]
Hocková, D.; Holý, A.; Masojídková, M.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. 5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidinesacyclic nucleoside phosphonate analogues with antiviral activity. J. Med. Chem., 2003, 46(23), 5064-5073.
[http://dx.doi.org/10.1021/jm030932o] [PMID: 14584956]
[19]
Hudson, H.R.; Wardle, N.J.; Bligh, S.W.A.; Greiner, I.; Grun, A.; Keglevich, G. N-heterocyclic dronic acids: Applications and synthesis. Mini Rev. Med. Chem., 2012, 12(4), 313-325.
[http://dx.doi.org/10.2174/138955712799829285] [PMID: 22303942]
[20]
Domínguez, M.J.; Sanmartín, C.; Font, M.; Palop, J.A.; San Francisco, S.; Urrutia, O.; Houdusse, F.; García-Mina, J.M. Design, synthesis, and biological evaluation of phosphoramide derivatives as urease inhibitors. J. Agric. Food Chem., 2008, 56(10), 3721-3731.
[http://dx.doi.org/10.1021/jf072901y] [PMID: 18452297]
[21]
Font, M.; Domínguez, M.J.; Sanmartín, C.; Palop, J.A.; San-Francisco, S.; Urrutia, O.; Houdusse, F.; García-Mina, J.M. Structural characteristics of phosphoramide derivatives as urease inhibitors. Requirements for activity. J. Agric. Food Chem., 2008, 56(18), 8451-8460.
[http://dx.doi.org/10.1021/jf801786d] [PMID: 18729463]
[22]
Gholivand, K.; Pooyan, M.; Mohammadpanah, F.; Pirastefar, F.; Junk, P.C.; Wang, J.; Ebrahimi Valmoozi, A.A.; Mani-Varnosfaderani, A. Synthesis, crystal structure and biological evaluation of new phosphoramide derivatives as urease inhibitors using docking, QSAR and kinetic studies. Bioorg. Chem., 2019, 86, 482-493.
[http://dx.doi.org/10.1016/j.bioorg.2019.01.064] [PMID: 30772649]
[23]
Brown, A.J.; Won, J.J.; Graham, R.L.; Dinnon, K.H., III; Sims, A.C.; Feng, J.Y.; Cihlar, T.; Denison, M.R.; Baric, R.S.; Sheahan, T.P. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral Res., 2019, 169, 104541.
[http://dx.doi.org/10.1016/j.antiviral.2019.104541] [PMID: 31233808]
[24]
Gholivand, K.; Mohammadpanah, F.; Pooyan, M.; Roohzadeh, R. Evaluating anti-coronavirus activity of some phosphoramides and their influencing inhibitory factors using molecular docking, DFT, QSAR, and NCI-RDG studies. J. Mol. Struct., 2022, 1248, 131481.
[http://dx.doi.org/10.1016/j.molstruc.2021.131481] [PMID: 34538931]
[25]
Qiu, S.; Hu, W.; Yu, B.; Yuan, B.; Zhu, Y.; Jiang, S.; Wang, B.; Song, L.; Hu, Y. Effect of functionalized graphene oxide with organophosphorus oligomer on the thermal and mechanical properties and fire safety of polystyrene. Ind. Eng. Chem. Res., 2015, 54(13), 3309-3319.
[http://dx.doi.org/10.1021/ie504511f]
[26]
Hummers, W.S., Jr.; Offeman, R.E. Preparation of graphitic oxide. J. Am. Chem. Soc., 1958, 80(6), 1339-1339.
[http://dx.doi.org/10.1021/ja01539a017]
[27]
Zhang, H.; Thomas, R.; Oupicky, D.; Peng, F. Synthesis and characterization of new copper thiosemicarbazone complexes with an ONNS quadridentate system: Cell growth inhibition, S-phase cell cycle arrest and proapoptotic activities on cisplatin-resistant neuroblastoma cells. J. Biol. Inorg. Chem., 2007, 13(1), 47-55.
[http://dx.doi.org/10.1007/s00775-007-0299-6] [PMID: 17909866]
[28]
Gholivand, K.; Sabaghian, M.; Eshaghi Malekshah, R. Synthesis, characterization, cytotoxicity studies, theoretical approach of adsorptive removal and molecular calculations of four new phosphoramide derivatives and related graphene oxide. Bioorg. Chem., 2021, 115, 105193.
[http://dx.doi.org/10.1016/j.bioorg.2021.105193] [PMID: 34339976]
[29]
Cao, Y.; Malekshah, R.E.; Heidari, Z.; Pelalak, R.; Marjani, A.; Shirazian, S. Molecular dynamic simulations and quantum chemical calculations of adsorption process using amino-functionalized silica. J. Mol. Liq., 2021, 330, 115544.
[http://dx.doi.org/10.1016/j.molliq.2021.115544]
[30]
Heidari, Z.; Pelalak, R.; Malekshah, R.E.; Pishnamazi, M.; Marjani, A.; Sarkar, S.M.; Shirazian, S. Molecular modeling investigation on mechanism of cationic dyes removal from aqueous solutions by mesoporous materials. J. Mol. Liq., 2021, 329, 115485.
[http://dx.doi.org/10.1016/j.molliq.2021.115485]
[31]
Heidari, Z.; Pelalak, R.; Eshaghi Malekshah, R.; Pishnamazi, M.; Rezakazemi, M.; Aminabhavi, T.M.; Shirazian, S. A new insight into catalytic ozonation of sulfasalazine antibiotic by plasma-treated limonite nanostructures: Experimental, modeling and mechanism. Chem. Eng. J., 2022, 428, 131230.
[http://dx.doi.org/10.1016/j.cej.2021.131230]
[32]
Malekshah, R.E.; Shakeri, F.; Aallaei, M.; Hemati, M.; Khaleghian, A. Biological evaluation, proposed molecular mechanism through docking and molecular dynamic simulation of derivatives of chitosan. Int. J. Biol. Macromol., 2021, 166, 948-966.
[http://dx.doi.org/10.1016/j.ijbiomac.2020.10.252] [PMID: 33152362]
[33]
Tudose, M.; Anghel, E.M.; Culita, D.C.; Somacescu, S.; Calderon-Moreno, J.; Tecuceanu, V.; Dumitrascu, F.D.; Dracea, O.; Popa, M.; Marutescu, L.; Bleotu, C.; Curutiu, C.; Chifiriuc, M.C. Covalent coupling of tuberculostatic agents and graphene oxide: A promising approach for enhancing and extending their antimicrobial applications. Appl. Surf. Sci., 2019, 471, 553-565.
[http://dx.doi.org/10.1016/j.apsusc.2018.11.242]
[34]
Chen, P.; Li, H.; Song, S.; Weng, X.; He, D.; Zhao, Y. Adsorption of dodecylamine hydrochloride on graphene oxide in water. Results Phys., 2017, 7, 2281-2288.
[http://dx.doi.org/10.1016/j.rinp.2017.06.054]
[35]
Stathi, P.; Gournis, D.; Deligiannakis, Y.; Rudolf, P. Stabilization of phenolic radicals on graphene oxide: An XPS and EPR study. Langmuir, 2015, 31(38), 10508-10516.
[http://dx.doi.org/10.1021/acs.langmuir.5b01248] [PMID: 26280685]
[36]
Marjani, A.; Nakhjiri, A.T.; Adimi, M.; Jirandehi, H.F.; Shirazian, S. Effect of graphene oxide on modifying polyethersulfone membrane performance and its application in wastewater treatment. Sci. Rep., 2020, 10(1), 2049.
[http://dx.doi.org/10.1038/s41598-020-58472-y] [PMID: 32029799]
[37]
Paulchamy, B.; Arthi, G.; Lignesh, B. A simple approach to stepwise synthesis of graphene oxide nanomaterial. J. Nanomed. Nanotechnol., 2015, 6, 1.
[38]
Doghish, A.S.; El-Sayyad, G.S.; Sallam, A.A.M.; Khalil, W.F.; El Rouby, W.M.A. Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer. RSC Advances, 2021, 11(46), 29052-29064.
[http://dx.doi.org/10.1039/D1RA04345E] [PMID: 35478542]
[39]
Tang, H.; Zhao, Y.; Shan, S.; Yang, X.; Liu, D.; Cui, F.; Xing, B. Wrinkle-and edge-adsorption of aromatic compounds on graphene oxide as revealed by atomic force microscopy, molecular dynamics simulation, and density functional theory. Environ. Sci. Technol., 2018, 52(14), 7689-7697.
[http://dx.doi.org/10.1021/acs.est.8b00585] [PMID: 29929371]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy